Geftinix 250mg Tablet

Introduction to Geftinix 250mg Tablet

Geftinix 250mg Tablet is a medication primarily used to treat a specific type of lung cancer known as non-small cell lung cancer (NSCLC). It is particularly effective for patients whose cancer has certain gene mutations called EGFR mutations. This medicine is usually prescribed to patients who have not undergone chemotherapy before.

Composition of Geftinix 250mg Tablet

The active ingredient in Geftinix 250mg Tablet is Gefitinib. This component works by targeting and blocking signals that promote cancer cell growth, specifically in cells with mutated EGFR receptors.

Uses of Geftinix 250mg Tablet

• Treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC).
• Effective for patients with specific EGFR gene mutations.
• Prescribed for patients who have not received prior chemotherapy.

Side effects of Geftinix 250mg Tablet

Common side effects:

• Diarrhea
• Skin rash
• Nausea
• Vomiting
• Loss of appetite

Serious side effects:

• Liver toxicity
• Lung inflammation
• Severe diarrhea leading to dehydration

Precautions of Geftinix 250mg Tablet

Geftinix should not be used by individuals without EGFR mutations, pregnant or breastfeeding women, or those with severe liver or kidney disease. It is also contraindicated for patients with a history of interstitial lung disease or those allergic to Gefitinib or any of its ingredients.

How to Take Geftinix 250mg Tablet

• Take one tablet orally once daily.
• Consume the tablet at the same time each day for consistency.
• Follow your doctor's instructions regarding dosage and duration.

Conclusion of Geftinix 250mg Tablet

Geftinix 250mg Tablet is a targeted therapy for treating non-small cell lung cancer with specific gene mutations. While it offers significant benefits, it is essential to be aware of its side effects and take necessary precautions. Always consult with your healthcare provider for personalized advice and treatment plans.